Single-Dose Escalation Study Followed by a Multiple-Dose Escalation Study of SKL24741 in Healthy Subjects

NCT04505397 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: SKL24741
DRUG: Placebo

Sponsor

SK Life Science, Inc.

Collaborators

[object Object]
[object Object]